Advertisement
Research Article| Volume 57, ISSUE 10, P421-424, October 2022

Download started.

Ok

Risk factors for lateral lymph node metastasis of papillary thyroid carcinoma in children

  • Duy Quoc Ngo
    Affiliations
    Department of Head and Neck Surgery, Vietnam National Cancer Hospital, 30 Cau Buou Street, Thanh Tri District, Hanoi, Vietnam

    Hanoi Medical University, 01 Ton That Tung Street, Dong Da District, Hanoi, Vietnam
    Search for articles by this author
  • Duong The Le
    Correspondence
    Corresponding author.
    Affiliations
    Department of Head and Neck Surgery, Vietnam National Cancer Hospital, 30 Cau Buou Street, Thanh Tri District, Hanoi, Vietnam
    Search for articles by this author
  • Quy Xuan Ngo
    Affiliations
    Department of Head and Neck Surgery, Vietnam National Cancer Hospital, 30 Cau Buou Street, Thanh Tri District, Hanoi, Vietnam
    Search for articles by this author
  • Quang Van Le
    Affiliations
    Department of Head and Neck Surgery, Vietnam National Cancer Hospital, 30 Cau Buou Street, Thanh Tri District, Hanoi, Vietnam

    Hanoi Medical University, 01 Ton That Tung Street, Dong Da District, Hanoi, Vietnam
    Search for articles by this author

      Abstract

      Introduction

      Lateral cervical lymph node metastases (LNM) for pediatric patients with papillary thyroid cancer (PTC) is a poor prognostic factor. We aimed to identify risk factors for lateral LNM.

      Methods

      This retrospective study had included 48 pediatric patients with papillary thyroid cancer underwent total thyroidectomy and central cervical lymphadenectomy at K hospital from 2016 to 2020.

      Results

      The number of patients in each T stage was as follows: 24 (50.0%) in stage 1, 9 (18.7%) in Stage 2, 8 (16.7%) in Stage 3, and 7 (14.6%) in Stage 4. Most of the patients had LNM with N1a and N1b rates of 83.3% and 62.5%, respectively. Lung metastases were observed at presentation in three patients (6.3%). Univariate analysis revealed that age (p = 0.021), male (p = 0.011), tumor size > 10 mm (p = 0.002), multifocality (p < 0.001), extrathyroidal extension (p = 0.001) and central LNM (p < 0.001) were factors that increase the risk of metastasis to lateral LNM.

      Conclusion

      Approximately 62.5% of pediatric patients with PTC exhibited lateral LNM at the time of diagnosis. Our study confirmed that multifocality, maximum tumor diameter, extrathyroidal extension and central LNM were independent risk factors for lateral LNM in pediatric PTC.

      Level of Evidence

      Level IV.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Golpanian S.
        • Perez E.A.
        • Tashiro J.
        • Lew J.I.
        • Sola J.E.
        • Hogan A.R.
        Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients.
        Pediatr Surg Int. 2016; 32: 201-208https://doi.org/10.1007/s00383-015-3855-0
        • Dermody S.
        • Walls A.
        • Harley E.H.
        Pediatric thyroid cancer: an update from the SEER database 2007-2012.
        Int J Pediatr Otorhinolaryngol. 2016; 89: 121-126https://doi.org/10.1016/j.ijporl.2016.08.005
        • Stack B.C.
        • Twining C.
        • Rastatter J.
        • Angelos P.
        • Baloch Z.
        • Diercks G.
        • et al.
        Consensus statement by the American Association of Clinical Endocrinology (AACE) and the American head and neck society endocrine surgery section (AHNS-ES) on pediatric benign and malignant thyroid surgery.
        Head Neck. 2021; 43: 1027-1042https://doi.org/10.1002/hed.26586
        • Al-Qurayshi Z.
        • Hauch A.
        • Srivastav S.
        • Aslam R.
        • Friedlander P.
        • Kandil E.
        A national perspective of the risk, presentation, and outcomes of pediatric thyroid cancer.
        JAMA Otolaryngol Head Neck Surg. 2016; 142: 472-478https://doi.org/10.1001/jamaoto.2016.0104
        • Lazar L.
        • Lebenthal Y.
        • Steinmetz A.
        • Yackobovitch-Gavan M.
        • Phillip M.
        Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents.
        J Pediatr. 2009; 154: 708-714https://doi.org/10.1016/j.jpeds.2008.11.059
        • Ngo D.Q.
        • Ngo Q.X.
        • Van Le Q.
        Pediatric thyroid cancer: risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma.
        Int J Pediatr Otorhinolaryngol. 2020; 133110000https://doi.org/10.1016/j.ijporl.2020.110000
        • Shayota B.J.
        • Pawar S.C.
        • Chamberlain R.S.
        MeSS: a novel prognostic scale specific for pediatric well-differentiated thyroid cancer: a population-based, SEER outcomes study.
        Surgery. 2013; 154: 429-435https://doi.org/10.1016/j.surg.2013.04.047
        • Ngo D.Q.
        • Tran T.D.
        • Ngo Q.X.
        • Le Q.V.
        Pediatric thyroid cancer: a rare case report with miliary pulmonary metastases from well-differentiated thyroid carcinoma.
        Clin Pediatr (Phila). 2020; 59: 1105-1108https://doi.org/10.1177/0009922820941207
        • Sugino K.
        • Nagahama M.
        • Kitagawa W.
        • Ohkuwa K.
        • Uruno T.
        • Matsuzu K.
        • et al.
        Risk stratification of pediatric patients with differentiated thyroid cancer: is total thyroidectomy necessary for patients at any risk?.
        Thyroid. 2020; 30: 548-556https://doi.org/10.1089/thy.2019.0231
        • Byeon H.K.
        • Kim S.B.
        • Oh H.S.
        • Kim H.K.
        • Choi I.H.
        • Kim H.
        • et al.
        Clinical analysis of pediatric thyroid cancer: a single medical institution experience of 18 years.
        Ann Otol Rhinol Laryngol. 2019; 128: 1152-1157https://doi.org/10.1177/0003489419868251
        • Francis G.L.
        • Waguespack S.G.
        • Bauer A.J.
        • Angelos P.
        • Benvenga S.
        • Cerutti J.M.
        • et al.
        Management guidelines for children with thyroid nodules and differentiated thyroid cancer.
        Thyroid. 2015; 25: 716-759https://doi.org/10.1089/thy.2014.0460
        • Liang W.
        • Sheng L.
        • Zhou L.
        • Ding C.
        • Yao Z.
        • Gao C.
        • et al.
        Risk factors and prediction model for lateral lymph node metastasis of papillary thyroid carcinoma in children and adolescents.
        Cancer Manag Res. 2021; 13: 1551-1558https://doi.org/10.2147/CMAR.S295420
        • Spinelli C.
        • Tognetti F.
        • Strambi S.
        • Morganti R.
        • Massimino M.
        • Collini P.
        Cervical lymph node metastases of papillary thyroid carcinoma, in the central and lateral compartments, in children and adolescents: predictive factors.
        World J Surg. 2018; 42: 2444-2453https://doi.org/10.1007/s00268-018-4487-z
        • Zimmerman D.
        • Hay I.D.
        • Gough I.R.
        • Goellner J.R.
        • Ryan J.J.
        • Grant C.S.
        • et al.
        Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades.
        Surgery. 1988; 104: 1157-1166
        • Wada N.
        • Sugino K.
        • Mimura T.
        • Nagahama M.
        • Kitagawa W.
        • Shibuya H.
        • et al.
        Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation.
        Ann Surg Oncol. 2009; 16: 3442-3449https://doi.org/10.1245/s10434-009-0673-4
        • Borson-Chazot F.
        • Causeret S.
        • Lifante J.-.C.
        • Augros M.
        • Berger N.
        • Peix J.-.L.
        Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer.
        World J Surg. 2004; 28: 1088-1092https://doi.org/10.1007/s00268-004-7630-y
        • Fridman M.
        • Krasko O.
        • Lam A.K.-.Y.
        Optimizing treatment for children and adolescents with papillary thyroid carcinoma in post-Chernobyl exposed region: the roles of lymph node dissections in the central and lateral neck compartments.
        Eur J Surg Oncol. 2018; 44: 733-743https://doi.org/10.1016/j.ejso.2017.12.004